-+ 0.00%
-+ 0.00%
-+ 0.00%

VIR BIOTECHNOLOGY TO PRESENT COMPLETE WEEK 96 DATA FROM PHASE 2 SOLSTICE CLINICAL TRIAL IN HEPATITIS DELTA AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER (EASL) CONGRESS 2026

Reuters·05/18/2026 20:05:00

Please log in to view news